biotech
Deep Value & Positive Catalysts
Scott Williams
Fiftyone Capital
Technology is reshaping modern medicine
Magellan Asset Management
Magellan Asset Management
Our take on Paradigm, one of Livewire's most-tipped small caps
Scott Williams
Fiftyone Capital
The New Criterion: two ways to play the pain game
Tim Boreham
Independent Investment Research
Paradigm: Deep value in a small-cap biotech?
Livewire Exclusive
Livewire
Alzheimer's: No Surprises
Michael Frazis
Frazis Capital Partners
Deep Diving For Asymmetric Upside - New Idea
Scott Williams
Fiftyone Capital
A profound med-tech breakthrough
Livewire Exclusive
Livewire
The Rules of Investing: The Age of Longevity
Livewire Exclusive
Livewire
Biotech stocks: the animal spirits are back
Tim Boreham
Independent Investment Research
